| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0345 | 8-bus-adenosine | Building block for syntheses of 8-BuS-AMP, ADP, ATP, and c-AMP |
|
| DCC0346 | 8-bus-adp Trisodium | Potent and selective inhibitor of NTPDase1 |
|
| DCC0347 | 8-bus-amp Disodium | Potent and selective inhibitor of NTPDase1 |
|
| DCC0348 | 8-bus-atp Tetrasodium | Potent and selective inhibitor of NTPDase1 |
|
| DCC0349 | 8-chloro-5-nitro-acridin-2,9-diol | Building Block |
|
| DCC0350 | 8-chloroadenosine | Inhibitor of RNA synthesis |
|
| DCC0351 | 8-cl-tibo | Specific non-nucleoside RT inhibitor (NNRTI) of HIV-1 RT |
|
| DCC0352 | 8-gly-carb | Novel inhibitor of nitric oxide formation in macrophages independent of effects on TNF |
|
| DCC0353 | 8-hydroxy-2-quinolinecarbaldehyde | Antitumor agent, displaying cytotoxicity against the human cancer cell lines, including MDA231, T-47D, Hs578t, SaoS2, K562, SKHep1,and Hep3B |
|
| DCC0354 | 8-nitro-cgmp | Unique cytoprotective mediator, inhibiting oxidative stress; Novel probe of the protein S-guanylation |
|
| DCC0355 | 8-pcpt-cgmp | Potent activator of cGMP-dependent protein kinase Ia, Ib and type II as well as of cGMP- gated ion channels |
|
| DCC0356 | 8-pip-camp | Potent and selective activator of protein kinase A (PKA) type I and II |
|
| DCC0357 | 9-deaza-csc | Dual human A2a antagonist/MAO-B inhibitor |
|
| DCC0358 | 9-hode | Endogenous peripheral TRPV1 ligand |
|
| DCC0359 | 9-ing-87 | Novel ATP-competitive GSK-3ß inhibitor, exhibiting potent antiproliferative activity |
|
| DCC0360 | 9-isopropylolomoucine | Inhibitor of cyclin-dependent kinases |
|
| DCC0361 | 9-me-1 | Novel, potent, mutant-selective BET bromodomain inhibitor, showing >100-fold selectivity for the L/V mutant over wild-type and excellent DMPK properties |
|
| DCC0362 | 9'-methoxypinoresinol | Novel natural anticancer agent, exhibiting potent cytotoxicity against PANC-1 human pancreatic cancer cell line under the normoglycemic condition |
|
| DCC0363 | 9-o-demethyltrigonostemone | Natural IDO1 inhibitor, cytotoxic and antiplasmodial agent |
|
| DCC0364 | A-1098807 | Selective TRPV1 antagonist |
|
| DCC0365 | A10--sbf | Fluorogenic A9 Peptide Probe, Interacting with Its Receptor Model HER2-DIVMP |
|
| DCC0366 | A-1165442 | Temperature-Neutral Transient Receptor Potential Vanilloid-1 (TRPV1) Antagonist with Analgesic Efficacy |
|
| DCC0367 | A-1165901 | Novel blocker of the activation of the TRPV1 channel by capsaicin, inducing hypothermia involving tail-skin, vasodilation at thermoneutrality, decreasing body temperature |
|
| DCC0368 | A-134974 Dihydrochloride | Selective adenosine kinase (AK) inhibitor |
|
| DCC0369 | A-1806262 | Negative control for A-192621 |
|
| DCC0370 | a-278637 | Novel potassium channel opener, more potent enantiomer |
|
| DCC0371 | A-286501 | Novel potent and orally active adenosine kinase inhibitor |
|
| DCC0372 | A2ar Antagonist 19 | Novel adenosine A2A receptor (A2AR) antagonist |
|
| DCC0373 | A-30312 | Multidrug Resistance (MDR) Modulator |
|
| DCC0374 | A-304121 | Novel and selective H3 receptor antagonist |
|
